Works by Cavaliere, Robert


Results: 18
    1

    A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 126, n. 2, p. 309, doi. 10.1007/s11060-015-1966-z
    By:
    • Robins, H.;
    • Zhang, Peixin;
    • Gilbert, Mark;
    • Chakravarti, Arnab;
    • Groot, John;
    • Grimm, Sean;
    • Wang, Fen;
    • Lieberman, Frank;
    • Krauze, Andra;
    • Trotti, Andy;
    • Mohile, Nimish;
    • Kee, Andrew;
    • Colman, Howard;
    • Cavaliere, Robert;
    • Kesari, Santosh;
    • Chmura, Steven;
    • Mehta, Minesh
    Publication type:
    Article
    2
    3

    Glioblastoma Multiforme.

    Published in:
    Neurology Research International, 2012, p. 1, doi. 10.1155/2012/819304
    By:
    • Sheehan, Jonas M.;
    • Cavaliere, Robert;
    • Farace, Elena;
    • Bredel, Markus;
    • Burri, Stuart H.
    Publication type:
    Article
    4

    A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 599, doi. 10.1007/s00280-020-04229-3
    By:
    • Collier, Katharine A.;
    • Valencia, Hugo;
    • Newton, Herbert;
    • Hade, Erinn M.;
    • Sborov, Douglas W.;
    • Cavaliere, Robert;
    • Poi, Ming;
    • Phelps, Mitch A.;
    • Liva, Sophia G.;
    • Coss, Christopher C.;
    • Wang, Jiang;
    • Khountham, Soun;
    • Monk, Paul;
    • Shapiro, Charles L.;
    • Piekarz, Richard;
    • Hofmeister, Craig C.;
    • Welling, D. Bradley;
    • Mortazavi, Amir
    Publication type:
    Article
    5
    6

    CNS germinomas: what is the best treatment strategy?

    Published in:
    Expert Review of Neurotherapeutics, 2008, v. 8, n. 10, p. 1527, doi. 10.1586/14737175.8.10.1527
    By:
    • Hadziahmetovic, Mersiha;
    • Clarke, James W.;
    • Cavaliere, Robert;
    • Mayr, Nina A.;
    • Montebello, Joseph F.;
    • Grecula, John C.;
    • Newton, Herbert B.;
    • Chang, Eric L.;
    • Lo, Simon S.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.

    Published in:
    Neuro-Oncology, 2016, v. 18, n. 8, p. 1137, doi. 10.1093/neuonc/now002
    By:
    • Wheeler, Lee A.;
    • Manzanera, Andrea G.;
    • Bell, Susan D.;
    • Cavaliere, Robert;
    • McGregor, John M.;
    • Grecula, John C.;
    • Newton, Herbert B.;
    • Lo, Simon S.;
    • Badie, Behnam;
    • Portnow, Jana;
    • Teh, Bin S.;
    • Trask, Todd W.;
    • Baskin, David S.;
    • New, Pamela Z.;
    • Aguilar, Laura K.;
    • Aguilar-Cordova, Estuardo;
    • Chiocca, E. Antonio
    Publication type:
    Article
    14
    15

    Neurologic toxicities of cancer therapies.

    Published in:
    Current Neurology & Neuroscience Reports, 2006, v. 6, n. 3, p. 218, doi. 10.1007/s11910-006-0009-8
    By:
    • Cavaliere, Robert;
    • Schiff, David
    Publication type:
    Article
    16
    17
    18